The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial
Open accessAbstract
Summary: Background : Helicobacter pylori eradication fails in about 10% of patients, particularly because of the occurrence of resistance to antibiotics and side‐effects. During anti‐H. pylori therapy, probiotics have been successfully used to reduce the incidence of side‐effects. Aim : To evaluate the effect of Bacillus clausii, a probiotic, on incidence (primary variable) and severity of antibiotic‐associated side‐effects during anti‐H. pylori therapy. Methods : One hundred and twenty H. pylori‐positive patients were randomly screened to receive: (i) a standard 7 days triple therapy with rabeprazole 20 mg b.d., clarithromycin 500 mg b.d. and amoxicillin 1 g b.d. and B. clausii t.d.s. (each preparation containing 2 × 10 9 spores) for 14 days starting from the first day of treatment. (ii) The same 7 days triple therapy and placebo t.d.s. for 14 days starting from the first day of treatment. Side‐effects were assessed using a validated questionnaire and were recorded for 4 weeks from the start of therapy. Results : The incidences of nausea, diarrhoea and epigastric pain in patients treated with B. clausii were significantly lower than in placebo group, in both PP and ITT analysis. Equally, intensity of nausea and diarrhoea in patients treated with B. clausii was significantly lower than in placebo group. There were no differences in adherence to treatment and H. pylori eradication rates between groups. Conclusion : In symptom‐free, H. pylori‐positive subjects B. clausii bacteriotherapy reduces the incidence of the most common side‐effects related to anti‐H. pylori antibiotic therapy compared with placebo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the results for two of the probiotic treatments were mixed, with a significant benefit of the specific probiotic treatment seen after 1 week, but not 2 weeks, in one study,49 and significantly fewer days with diarrhoea and shorter mean duration of diarrhoea episodes, but no significant difference in frequency of diarrhoea episodes, in the probiotic group compared with the placebo group in”
From Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide (2013) · cites this paper as [49]
In the citing paper
“All four studies reported a significant benefit of specific probiotic treatments compared with placebo.46–49”
From Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide (2013) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Malfertheiner, P., Mégraud, F., O'Morain, C. A., Hungin, A. P. S., Jones, R. H., Axon, A. T. R., Graham, D. Y., Tytgat, G. N. J., & The European Helicobacter Pylori Study Group (EHPSG) (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01169.x · Cited by 1,238
Fuller, R. (1991) · Gut · doi:10.1136/gut.32.4.439 · Cited by 844
Meta‐analysis: the effect of probiotic administration on antibiotic‐associated diarrhoea
Cremonini, F., Caro, S. D., Nista, E. C., Bartolozzi, F., Capelli, G., Gasbarrini, A., & Gasbarrini, A. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01318.x · Cited by 386
Self-citationCremonini, F., Caro, S., Covino, M., Armuzzi, A., Gabrielli, M., Santarelli, L., Nista, E. C., Cammarota, G., Gasbarrini, G., & Gasbarrini, A. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.07063.x · Cited by 341
Self-citationPeters, D. H., & Clissold, S. P. (1992) · Drugs · doi:10.2165/00003495-199244010-00009 · Cited by 298
Armuzzi, A., Cremonini, F., Bartolozzi, F., Canducci, F., Candelli, M., Ojetti, V., Cammarota, G., Anti, M., LORENZO, A. D., Pola, P., et al. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00923.x · Cited by 296
Self-citationIsolauri, E. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.6.1142s · Cited by 290
Laine, L., Hunt, R. H., El-Zimaity, H. M. T., Nguyen, B., Osato, M. S., & Spénard, J. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.t01-1-07288.x · Cited by 242
High eradication rates of Helicobacter pylori with a new sequential treatment
Zullo, A., Vaira, D., Vakil, N. B., Hassan, C., Gatta, L., Ricci, C., Francesco, V. D., Menegatti, M., Tampieri, A., Perna, F., et al. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01461.x · Cited by 221
Bacillus clausii Probiotic Strains
Urdaci, M. C., Bressollier, P., & Pinchuk, I. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000128925.06662.69 · Cited by 182
Research works printed but not linked: 1
- Ciffo F, 1987, Gastric resistance of Bacillus subtilis spores used in oral bacteriotherapy: in vitro studies, Farmaci e terapia, 3, 163
Cited by
Sorted by citations
Items 101–200 of 209
Update on therapeutic options for Helicobacter pylori-related diseases
Mégraud, F. (2005) · Current Infectious Disease Reports · doi:10.1007/s11908-005-0071-4 · Cited by 28
Kharwar, A. K., Bazaz, M. R., & Dandekar, M. P. (2022) · BMC Microbiology · doi:10.1186/s12866-022-02631-w · Cited by 27
From Antibiotic Resistance to Antibiotic Renaissance: A New Era in Helicobacter pylori Treatment
Godavarthy, P. K., & Puli, C. (2023) · Cureus · doi:10.7759/cureus.36041 · Cited by 26
Probiotics and prebiotics for gastrointestinal infections
Novak, J. D., & Katz, J. (2006) · Current Infectious Disease Reports · doi:10.1007/s11908-006-0005-9 · Cited by 26
Role of Probiotics in Eradication Therapy for Helicobacter pylori Infection
Kamiya, S., Yonezawa, H., & Osaki, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_369 · Cited by 26
de Castro, J.-A., Kesavelu, D., Lahiri, K. R., Chaijitraruch, N., Chongsrisawat, V., Jog, P. P., Liaw, Y. H., Nguyễn, G. K., Nguyễn, T. V. H., Pai, U., et al. (2020) · Tropical Diseases Travel Medicine and Vaccines · doi:10.1186/s40794-020-00120-4 · Cited by 26
Lim, E.-S. (2015) · Journal of the Korean Society for Applied Biological Chemistry · doi:10.1007/s13765-015-0094-y · Cited by 24
Lahiri, K. R., Singh, R., Apte, M., Patil, M. V., Taksande, A. M., Varona, R., Chatterjee, G., Verma, M., Brette, S., & Perez, M. I. (2022) · Tropical Diseases Travel Medicine and Vaccines · doi:10.1186/s40794-022-00166-6 · Cited by 23
Probiotic use in irritable bowel syndrome
Young, P., & Cash, B. D. (2006) · Current Gastroenterology Reports · doi:10.1007/s11894-006-0053-1 · Cited by 22
Stachelska, M. A., Karpiński, P., & Kruszewski, B. (2024) · Nutrients · doi:10.3390/nu17010009 · Cited by 26
Mărginean, C. M., Cioboată, R., Olteanu, M., Vasile, C. M., Popescu, M., Popescu, A. I. S., Bondari, S., Pîrșcoveanu, D. F. V., Mărginean, I. C., Iacob, G. A., et al. (2022) · Antibiotics · doi:10.3390/antibiotics12010060 · Cited by 24
The Use of Probiotics in Helicobacter pylori Eradication Therapy
Medeiros, J. A., & Pereira, M.-I. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182702dbc · Cited by 20
Cloning and expression of bacteriocins of Pediococcus spp.: A review
Kumar, B., Balgir, P. P., Kaur, B., & Garg, N. (2011) · Archives of Clinical Microbiology · Cited by 20
Use of Bacillus in Human Intestinal Probiotic Applications
Schultz, M., Burton, J. P., & Chanyi, R. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00011-2 · Cited by 20
Bacillus clausii: A Review into Story of Its Probiotic Success and Potential Food Applications
Sadrimovahed, M., & Ulusoy, B. H. (2024) · Fermentation · doi:10.3390/fermentation10100522 · Cited by 18
Therapeutic Properties of Probiotic Bacteria
Trachoo, N., & ., C. B. (2005) · Journal of Biological Sciences · doi:10.3923/jbs.2006.202.208 · Cited by 16
Helicobacter pyloriinfection in children: management and pharmacotherapy
Sabbi, T., Angelis, P. D., & Dall’Oglio, L. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.4.577 · Cited by 16
Pirozzi, C., Opallo, N., Coretti, L., Lama, A., Annunziata, C., Comella, F., Melini, S., Buommino, E., Mollica, M. P., Aviello, G., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114860 · Cited by 15
Role of Probiotics in Health and Diseases
Collado, M. C., Laparra, J. M., Frías, R., Lee, Y. K., Salminen, S., Lim, A., & Tan, H. (2008) · Wiley eBooks · doi:10.1002/9780470432624.ch4 · Cited by 15
Production of High‐Quality Probiotics by Fermentation
Anandharaj, M., Rani, R. P., & Swain, M. R. (2017) · Wiley eBooks · doi:10.1002/9781119048961.ch10 · Cited by 14
Asia‐Pacific Survey on the Management of Helicobacter pylori Infection
Otani, K., Dao, H. V., Pittayanon, R., Liu, H., Chuah, K. H., Hsiang, J. C., Zhang, N., Higashimori, A., Fujiwara, Y., & The Upper GI Focus Group of the APAGE‐ELC (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16862 · Cited by 13
Duysburgh, C., Verstrepen, L., den Broeck, M. V., Righetto, Z., & Perez, M. I. (2023) · Nutrients · doi:10.3390/nu15030653 · Cited by 15
Kim, C. G., Song, H. J., Kook, M., Hong, E. K., Park, S., Lee, J. Y., Lee, J. H., Ryu, K. W., Kim, Y., Bae, J.-M., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01482.x · Cited by 12
Lazebnik, L. B., Дехнич, Н. Н., Sitkin, S. I., Atrushevich, V. G., Avalueva, E. B., Бакулин, И. Г., Бакулина, Н. В., Baryshnikova, N. V., Belousova, L. N., Bordin, D. S., et al. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-232-12-49-145 · Cited by 14
In vitro and in vivo evaluation of Bacillus clausii against Schistosoma mansoni
Cruz, C. S., França, W. W. M., de Araújo, H. D. A., Ximenes, E. C. P. A., de Souza, V. M. O., Albuquerque, M. C. P. A., Aires, A. D. L., & Costa, V. M. A. (2022) · Acta Tropica · doi:10.1016/j.actatropica.2022.106669 · Cited by 11
Baryshnikova, N. V. (2012) · Beneficial Microbes · doi:10.3920/bm2011.0023 · Cited by 11
Kwon, S. B., Lee, K. L., Kim, J. S., Lee, J., Kim, W. K., Jung, Y. J., Jeong, J. B., Kim, J. W., & Kim, B. G. (2010) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2010.56.4.229 · Cited by 11
Helicobacter pylori in 2013: Multiplying Genomes, Emerging Insights
Ahmed, N., Loke, M. F., Kumar, N., & Vadivelu, J. (2013) · Helicobacter · doi:10.1111/hel.12069 · Cited by 10
Chen, Y., Zhao, Y., Tan, R. Y.-S., Zhang, P.-Y., Long, T., Shi, Y., & Zheng, H. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/2771094 · Cited by 10
Bacillus spp. and Their Biotechnological Roles in Green Industry
Feto, N. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-44409-3_7 · Cited by 10
Probiotic, Prebiotic and Synbiotics in the Prevention of Lifestyle Disorders
Chauhan, A. P. S., Ranjan, A., Basniwal, R. K., & Jindal, T. (2016) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2016.512.102 · Cited by 9
Kyriakos, N., Papamichael, K., Roussos, A., Theodoropoulos, I., Karakoidas, C., Smyrnidis, A., Archavlis, E. J., Lariou, K., & Mantzaris, G. J. (2013) · Hospital chronicles/Hospital Chronicles · doi:10.2015/hc.v8i3.538 · Cited by 9
Challenges of Beneficial Health Claims
Siró, I. (2011) · Microbiology monographs · doi:10.1007/978-3-642-20838-6_10 · Cited by 9
Lojanatorn, P., Phrommas, J., Tanpowpong, P., Getsuwan, S., Lertudomphonwanit, C., & Treepongkaruna, S. (2023) · Indian Pediatrics · doi:10.1007/s13312-023-2907-0 · Cited by 8
Probiotics are associated with a decreased risk of antibiotic-associated diarrhoea
Cremonini, F., & Videlock, E. J. (2012) · BMJ Evidence-Based Medicine · doi:10.1136/eb-2012-100863 · Cited by 8
Self-citationQuantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction
Perotti, M., Mancini, N., Cavallero, A., Carletti, S., Canducci, F., Burioni, R., & Clementi, M. (2005) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2005.10.010 · Cited by 8
THERAPEUTIC POTENTIAL OF MODERN PROBIOTICS
Игоревна, У. Н. (2013) · Педиатрическая фармакология · doi:10.15690/pf.v10i2.644 · Cited by 8
Probiotics for Antibiotic-Associated Diarrhea
Videlock, E. J., & Cremonini, F. (2012) · JAMA · doi:10.1001/jama.2012.8735 · Cited by 8
Self-citationDhakephalkar, T., Pisu, V., Margale, P., Chandras, S., Shetty, D., Wagh, S. A., Dagar, S. S., Kapse, N. G., & Dhakephalkar, P. K. (2024) · Microorganisms · doi:10.3390/microorganisms12091771 · Cited by 8
Surolia, R., Prakash, A., & Singh, A. (2023) · Journal of Food Measurement & Characterization · doi:10.1007/s11694-023-02254-3 · Cited by 7
Probiotics for cure of Helicobacter pylori infection: A review
Alvi, S., Javeed, A., Akhtar, B., Sharif, A., & Akhtar, M. F. (2016) · International Journal of Food Properties · doi:10.1080/10942912.2016.1233432 · Cited by 7
Probiotics: A New Treatment for Antibiotic-Associated Diarrhea?
Meier, R. F. (2005) · Digestion · doi:10.1159/000087601 · Cited by 7
y Abreu, A. T. A., Vázquez-Frías, R., Marzet, C. B., stefanolo, J. P., Mejía, A. C., Fernández, L. M. B., Laudanno, O. M. O., Salazar, D. D. J. R., Serrano, M. C. C., Cárdenas-Garzón, K., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14050439 · Cited by 6
Giua, C., Romano, F., Keber, E., Pellegrino, P., Perez, M. I., Uboldi, M. C., Bastianini, M. L., Belei, E., Carpinella, F., Casu, S., et al. (2023) · Drugs - Real World Outcomes · doi:10.1007/s40801-023-00402-1 · Cited by 6
Sharma, A. K., Mohan, P., & Nayak, B. B. (2005) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.19071 · Cited by 5
Mazzantini, D., Calvigioni, M., Celandroni, F., Saba, A., & Ghelardi, E. (2025) · Biomolecules · doi:10.3390/biom15091294 · Cited by 4
Mazzantini, D., & Ghelardi, E. (2026) · Nutrients · doi:10.3390/nu18091378 · Cited by 4
Kandil, A. (2021) · European Journal of Biology · doi:10.26650/eurjbiol.2021.931755 · Cited by 4
Navarra, P., Milleri, S., Perez, M. I., Uboldi, M. C., Pellegrino, P., Fer, B. B. D., & Morelli, L. (2021) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-021-00676-2 · Cited by 4
Sharma, A. K., PURI, N., Mathur, M., & MATHUR, A. (2022) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2022.v15i4.44199 · Cited by 4
Русланович, К. М., Andronova, T. M., & Матвеенко, М. Е. (2016) · Terapevticheskii arkhiv · doi:10.17116/terarkh20168812140-148 · Cited by 4
Helicobacter pylori& beyond: pediatric peptic ulcer disease
Shashidhar, H., Flomenhoft, D. R., & Tolia, V. K. (2008) · Therapy · doi:10.2217/14750708.6.1.65 · Cited by 3
Probiotics: common genera, mechanisms, current phase and the future
Hu, Z. (2024) · Highlights in Science Engineering and Technology · doi:10.54097/gajke929 · Cited by 3
Structure and Function of the Human Microbiome
Ritchie, M. L. (2012) · Library and Archives Canada (Government of Canada) · Cited by 3
Probiotics as adjunctive therapy for eradication of Helicobacter pylori infection
Goel, A., & Aggarwal, R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010776 · Cited by 3
Treatment Options for Helicobacter Pylori Infection in the Elderly
Pilotto, A., Franceschi, M., Perri, F., Orsitto, G., & Mario, F. D. (2006) · Aging Health · doi:10.2217/1745509x.2.4.661 · Cited by 3
Probiotics and Helicobacter pylori
Francavilla, R., Tripaldi, M., Massimiliano Praitano, M., Lionetti, E., & Miniello, V. L. (2013) · CRC Press eBooks · doi:10.1201/b15561-17 · Cited by 3
Ai, D. (2017) · Advanced Research in Gastroenterology & Hepatology · doi:10.19080/argh.2017.05.555665 · Cited by 3
Eradication therapy of helicobacteriosis with probiotics, problems, and prospects
Ермоленко, Е. И., Молостова, А. С., & Сергеевич, Г. Н. (2021) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-193-9-60-72 · Cited by 3
Bacillus Species—Elucidating the Dilemma on Their Probiotic and Pathogenic Traits
Gayathri, L., & Krubha, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822909-5.00015-0 · Cited by 2
Abdou, M. A., Awny, N., & Abou-Zeid, A. A. (2012) · Journal of Consumer Protection and Food Safety · doi:10.1007/s00003-012-0772-1 · Cited by 2
EFFECT OF FEEDS SUPPLEMENTED WITH ASPARAGUS RACEMOSUS ON MILK PRODUCTION OF INDIGENOUS COWS
Garg, N. (2015) · Mintage journal of pharmaceutical and medical sciences · Cited by 2
Probiotics as an Alternative Therapy for Helicobacter pylori-Associated Diseases
Vale, F. F., Vítor, J. M. B., & Oleastro, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-55936-8_24 · Cited by 2
Trujillo, G. J., Regino, W. O., & Estrada-Orozco, K. (2022) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v71n2.98018 · Cited by 2
Gu, Q. (2023) · Springer eBooks · doi:10.1007/978-981-99-2661-9_6 · Cited by 2
Probiotics and Helicobacter pylori infection
Kamiya, S., Takahashi, M., Manzoku, T., Oka, K., Osaki, T., Hanawa, T., Kurata, S., & Taguchi, H. (2006) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v18i3-4.7686 · Cited by 2
Sequential therapy for Helicobacter pylori infection with and without probiotics
Rafiei, R., Ebrahimi, A., Bahrami, M., Nazari, M., Torabi, Z., Ebrahimi, A., Rafiei, F., Hosseini, S., & Ashkani‐Esfahani, S. (2020) · Gastroenterology & Hepatology Open Access · doi:10.15406/ghoa.2020.11.00444 · Cited by 2
Krishna, A., Marakala, V., D’souza, R. T., Shenoy, V., D'souza, S., Jakribettu, R. P., & Baliga, M. S. (2024) · Current Probiotics · doi:10.2174/0126666499301297240531055350 · Cited by 1
Li, X., Lin, S., Li, X., Lu, K., Ma, R., Song, K., Lin, Y., Wang, L., & Zhang, C. (2024) · Aquaculture Reports · doi:10.1016/j.aqrep.2024.102491 · Cited by 1
Probiotics for Antibiotic-Associated Diarrhea—Reply
Hempel, S., Miles, J. N. V., & Shekelle, P. (2012) · JAMA · doi:10.1001/jama.2012.8738 · Cited by 1
Choueiry, E., Kamel, R., Chacar, H., Mouawad, P., & Sacy, R. (2017) · International Journal of Clinical Pediatrics · doi:10.14740/ijcp269w · Cited by 1
Ulcer Disease andHelicobacter pyloriInfection: Etiology and Treatment
Chiba, N. (2010) · Wiley eBooks · doi:10.1002/9781444314403.ch6 · Cited by 1
Aß(25-35) Peptide Induces Cell Death in PC12 Cells via Mitochondrial Damage and Cytochrome c Release
., C. C. A., Pezzotti, M., Mezzogori, D., ., M. E. C., Misiti, F., Giardina, B., & Orsini, F. (2005) · Journal of Biological Sciences · doi:10.3923/jbs.2006.140.145 · Cited by 1
Folwarski, M., & Dobosz, M. (2010) · Polish Journal of Surgery · doi:10.2478/v10035-010-0071-4 · Cited by 1
Midtvedt, T. (2006) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v18i2.7692 · Cited by 1
A SIMPLE METHOD FOR ISOLATION OF SOME BACILLUS STRAINS WITH AN EXPRESSED ANTI-CANCER ACTIVITY
Малков, С. В., Markelov, V. V., Polozov, G. Y., Barabanschikov, B. I., Sobchuk, L. I., Kozhevnikov, A. Y., Marotta, F., & Trushin, M. V. (2006) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Guarner, F., Khan, A. G., Garisch, J., Gangl, A., & Paula, J. A. D. (2008)
Martínez, J. A., del Moral, A. A. M., & Asturgano, D. P. (2005)
Probiotics and H. pylori Infection
Franceschi, F., Marco, G. D., Roccarina, D., Giupponi, B., Gigante, G. E., & Gasbarrini, A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374938-3.00017-7
Self-citationBurnett, B. P. (2017) · Advanced Research in Gastroenterology & Hepatology · doi:10.19080/argh.2017.06.555685
Probiotics can prevent drug-induced gastrointestinal symptoms
Plomer, M., & Perez, M. I. (2022) · Evidence for Self-Medication · doi:10.52778/efsm.22.0009
Los probióticos pueden prevenir los síntomas gastrointestinales inducidos por los fármacos
Plomer, M., & Perez, M. I. (2022) · Evidence for Self-Medication · doi:10.52778/efsm.22.0011
A probiotikumok megelőzhetik a gyógyszerek okozta gyomor-bélrendszeri tüneteket
Plomer, M., & Perez, M. I. (2022) · Evidence for Self-Medication · doi:10.52778/efsm.22.0012
Probiotika können arzneimittelinduzierten gastrointestinalen Symptomen vorbeugen
Plomer, M., & Perez, M. (2022) · Evidence of self-medication · doi:10.52778/efsm.22.0010
Plomer, M., & Perez, M. I. (2022) · Evidence for Self-Medication · doi:10.52778/efsm.22.0079
Пробиотики могут предотвращать желудочно-кишечные симптомы, вызванные приемом лекарственных средств
Plomer, M., & Perez, M. I. (2022) · Evidence for Self-Medication · doi:10.52778/efsm.22.0078
I probiotici possono prevenire i sintomi gastrointestinali indotti dai farmaci
Plomer, M., & Perez, M. I. (2022) · Evidence for Self-Medication · doi:10.52778/efsm.22.0013
Os probióticos podem impedir os sintomas gastrointestinais induzidos pelos fármacos
Plomer, M., & Perez, M. I. (2022) · Evidence for Self-Medication · doi:10.52778/efsm.22.0014
Probiyotikler ilaca bağlı gastrointestinal semptomları önleyebilir
Plomer, M., & Perez, M. I. (2022) · Evidence for Self-Medication · doi:10.52778/efsm.22.0077
Probiotic Identity from Spore: Focus on Bacillus Probiotics
Bhanuramanand, K., Veena, P. V. S., Haritha Rani, B., Mehta, D. S., DeSouza, A., & Nalam, M. R. (2023) · Springer eBooks · doi:10.1007/978-981-99-1463-0_26
Righetto, Z., Márquez, D., & Perez, M. I. (2023) · Evidence for Self-Medication · doi:10.52778/efsm.23.0036
Righetto, Z., Márquez, D., & Perez, M. I. (2023) · Evidence of self-medication · doi:10.52778/efsm.23.0035
Righetto, Z., Márquez, D., & Perez, M. I. (2023) · Evidence for Self-Medication · doi:10.52778/efsm.23.0034
Ettinger, G. (2014) · Scholarship@Western (Western University)
[Helicobacter pylori infection and probiotics].
Kamiya, S. (2007) · Nippon Saikingaku Zasshi · doi:10.3412/jsb.62.271
Kharwar, A. K., Bazaz, M. R., & Dandekar, M. P. (2022) · Figshare · doi:10.6084/m9.figshare.21151249
Kharwar, A. K., Bazaz, M. R., & Dandekar, M. P. (2022) · Figshare · doi:10.6084/m9.figshare.21151252
Kharwar, A. K., Bazaz, M. R., & Dandekar, M. P. (2022) · Figshare · doi:10.6084/m9.figshare.21151255
Metadata
- Authors
- Nista, E. C., Candelli, M., Cremonini, F., Cazzato, I. A., Zocco, M. A., Franceschi, F., Cammarota, G., Gasbarrini, G., & Gasbarrini, A.
- Affiliations
- Università Cattolica del Sacro Cuore (IT)
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2004-11
- Volume
- 20
- Issue
- 10
- Pages
- 1181-1188
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2120773585
- Cited by
- 212
- References
- 27
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 12 · 2023: 15 · 2022: 29 · 2021: 8 · 2020: 6 · 2019: 7 · 2018: 2 · 2017: 9 · 2016: 11 · 2015: 9 · 2014: 8 · 2013: 16 · 2012: 11
- FWCI
- 11.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Alimentary Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Bacillus clausii, probiotics, Helicobacter pylori eradication, antibiotic adverse effects, triple therapy, clarithromycin, amoxicillin, rabeprazole, nausea, diarrhea, epigastric pain, Helicobacter pylori infection
- MeSH terms
- Adolescent, Adult, Aged, Amoxicillin, Anti-Ulcer Agents, Bacillus, Benzimidazoles, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Omeprazole, Prospective Studies, Helicobacter pylori, Helicobacter Infections, Clarithromycin, Probiotics, 2-Pyridinylmethylsulfinylbenzimidazoles, Rabeprazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
